Home › Funds › PFM Health Sciences, LP › KOD
PFM Health Sciences, LP position in KOD
KODIAK SCIENCES INC · Health Care
PFM Health Sciences, LP reported holding 109,547 shares of KOD (KODIAK SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 1.06% of its reported portfolio and ranking #36 among its reported holdings. PFM Health Sciences, LP has disclosed KOD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's KOD position evolved
PFM Health Sciences, LP first disclosed a stake in KOD in Q1 2026 at 114,719 shares (US$4.4M). The position peaked in Q3 2026 at 109,547 shares, worth US$10.4M. Across 3 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 109,547 shares valued at US$10.4M — a reduction of -83,768 shares quarter over quarter.. Notable position changes include a 69% increase in Q2 2026 (shares rose 143% over the following quarter), a 43% trim in Q3 2026 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 114.72K | $4.37M | New |
| Q2 2026 | 193.31K | $7.53M | Add |
| Q3 2026 | 109.55K | $10.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KOD and 13F data
KOD (KODIAK SCIENCES INC) is a Health Care company. 79 other funds we track also report a position in KOD — the largest reported positions include BAKER BROS. ADVISORS LP (US$776.1M), RTW INVESTMENTS, LP (US$141.1M), TCG Crossover Management, LLC (US$137.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KOD
- BAKER BROS. ADVISORS LP 19.92M sh · $776.05M · Q2 2026
- RTW INVESTMENTS, LP 1.49M sh · $141.06M · Q3 2026
- TCG Crossover Management, LLC 1.45M sh · $137.04M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 750.17K sh · $71.12M · Q3 2026
- BRAIDWELL LP 1.79M sh · $69.63M · Q2 2026
- Boxer Capital Management, LLC 1.48M sh · $57.57M · Q2 2026
- Board of Trustees of The Leland Stanford Junior University 691.77K sh · $26.95M · Q2 2026
- Squadron Capital Management LLC 500.00K sh · $19.48M · Q2 2026
- ADAPT Investment Managers SA 200.00K sh · $18.96M · Q3 2026
- Ghisallo Capital Management LLC 200.00K sh · $18.96M · Q3 2026
- Parkman Healthcare Partners LLC 186.00K sh · $17.63M · Q3 2026
- BOONE CAPITAL MANAGEMENT LLC 378.01K sh · $14.73M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held KOD?
PFM Health Sciences, LP has disclosed KOD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is PFM Health Sciences, LP's current position in KOD?
As of Q3 2026, PFM Health Sciences, LP holds 109.55K shares of KOD (KODIAK SCIENCES INC), valued at $10.39M, representing 1.06% of its reported portfolio and ranking #36.
Has PFM Health Sciences, LP been buying or selling KOD?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP reduced its position in KOD. The position peaked in Q3 2026 at 109.55K shares.
Which other funds hold KOD?
Other major institutional holders of KOD include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, TCG Crossover Management, LLC, among 79 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.